Curatively Resected Stage III Colon Cancer
1 clinical trials · Condition
◉ Watch Curatively Resected Stage III Colon Cancer
| Record | Firm | Date |
|---|---|---|
| Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin (NCT00977717) | Samsung Medical Center | 2008-09-01 |
Track Curatively Resected Stage III Colon Cancer automatically
Every clearance here is in the API, with alerts when new ones post.